Opinion

Iron Overload in Non-HFE Liver Disease: Not all Iron is Ready to Strike
- Author:
- Paul Martin, MD
- Lawrence S. Friedman, MD
Publish date: February 5, 2024
In any patient with chronic liver disease, an elevated serum ferritin or an elevated iron saturation should prompt testing for HFE mutations to...
Opinion

Statins and the liver: Not harmful and perhaps beneficial
- Author:
- Paul Martin, MD
- Lawrence S. Friedman, MD
Publish date: December 5, 2023
Statins should not be withheld in patients with liver disease when indicated — with a few caveats.
Opinion

Hepatic presentations of celiac disease
- Author:
- Lawrence S. Friedman, MD
- Paul Martin, MD
Publish date: September 11, 2023
Liver biopsy findings may include variable degrees of steatosis, inflammation, and fibrosis.
Opinion

Incidental hepatic steatosis
- Author:
- Lawrence S. Friedman, MD
- Paul Martin, MD
Publish date: July 13, 2023
It is important to identify patients at risk of progressive fibrosis.
News
Introduction to Clinical Practice Update Committee articles
- Author:
- David A. Katzka, MD
- Lawrence S. Friedman, MD
- John M. Inadomi, MD
- Anthon
Publish date: July 18, 2016